AVD's Copper Catch-22: A Beaten-Down Crop Chemist Bets on Pricing Power as Volumes Fade
American Vanguard posts a 20% H1 EBITDA gain on gross-margin recovery, while juggling copper-driven Brazil demand destruction, GLP-1 diets, and a freight-cost pass-through.
AVD · Earnings Call · 2026-08-10
A micro-cap crawling out of a 90% drawdown
American Vanguard (AVD) reported Q2 2026 results on August 10 that look grim on their face: net sales down 10% year over year, gross margin down a point, and adjusted EBITDA collapsing from $11M to $600K in the quarter. But the company is selling a more patient story, and the tape half-believes it — the stock, down 71% over the last 16 years and a staggering 93.7% from its 2012 peak, has been essentially flat over the past 90 days after clawing back some ground. Management's message is that difficult market conditions notwithstanding, the cost work is landing: first-half adjusted EBITDA rose more than 20% to $17M on roughly flat sales, and gross margin improved to 30% from 29%. “Despite these difficult market conditions, we are outperforming our peers in The US markets.” — Douglas A. Kaye, Chief Executive Officer · 2026-08-10 The operating-leverage thesis shows up even more clearly in the fundamentals. Gross margin reached 31.1% in Q1 2026, up 5 points year over year on just +7% revenue growth, a sharp inflection off the 14% trough in Q4 2024. The flip side is a balance sheet still under pressure: effective net cash sits at −$196M, and interest coverage, while improving, is still −0.7x. This is a company buying time to refinance.The copper catch-22 in Brazil
The most genuinely new theme on this call — one with no prior footprint in AVD's keyword history — is the Brazil copper fungicide dynamic. AVD's key Brazilian product is priced off London Metal Exchange copper, and when copper costs rose, the company raised prices. Demand fell. CEO Dak Kaye was candid about the elasticity trap:This is the mirror image of the new product development push management is driving elsewhere — a reminder that in crop protection, pricing power only sticks when the product is sticky. Meanwhile international sales were down 13% in the first half, dragged by Brazil's copper hit, Mexico's shrinking agave acres, and Central America's dry spell.the pricing pressure ... is not a decrease in pricing that we are seeing. We are seeing an increase in pricing specifically ... with 1 of our big products there being a copper fungicide it is directly related to copper LME pricing ... as that cost position is going up on the copper fungicide, the demand has gone down relative there.
GLP-1 diets and El Niño squeeze the demand side
AVD is framing part of its market softness as structural, not just cyclical. Management pointed directly at the GLP-1 drug usage boom and the multi-year decline in alcohol consumption as forces reshaping what consumers eat — and therefore what growers plant. “some underlying structural and behavioral shifts in consumption patterns are impacting agricultural markets, including the multiyear decline in overall alcohol consumption as well as the rapid uptake of GLP 1 drug usage and the effect this is having on consumer eating habits.” — Douglas A. Kaye, Chief Executive Officer · 2026-08-10 That ties an $82M micro-cap into one of the largest global themes of the year. On top of that, el niño delayed has hammered international markets, compounded by the Middle East conflict pushing up fuel and fertilizer costs. The contrast with last quarter is telling. In May, management was touting volume as the main US driver and warning that generics were flooding in — “the generics are definitely coming into the marketplace fairly heavily and in the environment that we have here in the ag cycle” — Douglas Kaye, Chief Executive Officer · 2026-05-06 — and in November they were celebrating more normal demand. “What we're seeing is more normal demand in the U.S. crop business. Therefore, we're not having to incentivize as much as we have ... in Q1.” — Douglas Kaye, Chief Executive Officer · 2025-11-10 Today the emphasis has shifted from volume to price, with management signaling July pricing actions on freight are beginning to flow through.The freight pass-through and a 2028 promise
Freight costs clipped H1 margins by $2.2M, or 90 basis points, and management says the recovery is already underway. “We have taken pricing actions in the market to recover these higher costs and expect to see these initiatives begin to flow through our results in the second half of 26.” — Douglas A. Kaye, Chief Executive Officer · 2026-08-10 The forward promise is what carries most of the risk: management reiterated full-year 2026 guidance of $530–550M in sales and $44–48M in adjusted EBITDA, and repeated the 2028 target of more than $600M in annualized run-rate revenue with double-digit EBITDA margins.Whether the copper fungicide lesson — that raising prices can cost you the volume — haunts the broader pricing strategy is the question that will define whether this beaten-down micro-cap finally turns the corner.we need to move our EBITDA margins into the double digit area as soon as possible, and that is top priority.